Inclusive Invasive Physiological Assessment in Angina Syndromes Registry
- Conditions
- Coronary Artery DiseaseMicrovascular Coronary Artery Disease
- Interventions
- Diagnostic Test: Resting distal coronary to aortic pressure ratio, Fractional flow reserve, Coronary Flow Reserve, Microvascular resistance
- Registration Number
- NCT04485234
- Brief Summary
This study evaluates the prognostic value and potential therapeutic impact of combined pressure and flow measurements in the evaluation of epicardial coronary stenosis and microvascular function.
- Detailed Description
ILIAS registry is a global effort to gather lesion-level data on the diagnostic and prognostic value of combined coronary pressure and flow measurements in clinical practice. Data is gathered from 7 nations (The Netherlands, Korea, Japan, Spain, Italy, Denmark, USA), using either coronary Doppler velocity measurements or coronary thermodilution measurements to obtain invasive coronary flow assessment. Patient treatment was governed by the local clinical practice guidelines at the time of the invasive procedure, but was at the operator's discretion. A standardized data collection sheet was used and all study adopted standardized definition of patient's baseline characteristics, clinical outcomes, and physiologic data. In case of acute coronary syndrome (unstable angina, non-ST-segment elevation myocardial infarction, and ST-segment elevation myocardial infarction), only non-culprit vessel evaluation was used.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2322
- underwent combined measurements of coronary pressure and flow for at least 1native coronary artery
- hemodynamic instability
- culprit vessel of acute coronary syndrome
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description All patients Resting distal coronary to aortic pressure ratio, Fractional flow reserve, Coronary Flow Reserve, Microvascular resistance All lesions undergo assessment with coronary pressure sensor and either Doppler velocity or coronary thermodilution
- Primary Outcome Measures
Name Time Method Major adverse cardiac events 10 years Cumulative incidence of a composite of any death, any myocardial infarction, or any ischemia-driven revascularization
- Secondary Outcome Measures
Name Time Method Individual components of MACE and TVF 10 years Cumulative incidence of the individual components of MACE and TVF
Target vessel failure 10 years Cumulative incidence of a composite of cardiac death, target-vessel related myocardial infarction, or target-vessel revascularization
Trial Locations
- Locations (12)
Cincinnati University Medical Center
🇺🇸Cincinnati, Ohio, United States
Catholic University of the Sacred Heart
🇮🇹Roma, Italy
Gifu Heart Center
🇯🇵Gifu, Japan
Seoul National University Hospital
🇰🇷Seoul, Korea, Republic of
Amsterdam UMC - location AMC
🇳🇱Amsterdam, Netherlands
Toda Central General Hospital
🇯🇵Toda, Japan
Tsuchiura Kyodo General Hospital
🇯🇵Tsuchiura, Japan
Amphia Hospital
🇳🇱Breda, Netherlands
Tergooi
🇳🇱Blaricum, Netherlands
Aarhus University Hospital
🇩🇰Aarhus, Denmark
Hospital Clinico San Carlos
🇪🇸Madrid, Spain
Samsung Medical Center
🇰🇷Seoul, Korea, Republic of